TALPHERA, INC. (TLPH) Current Ratio
- Current ratio · latest quarter: Value 4.29×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 4.29× | Current assets / current liabilities. $17.99M ÷ $4.19M ≈ 4.29× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 17.99M USD | Assets, Current |
| Current obligations | 4.19M USD | Liabilities, Current |
| Cash and equivalents | 742.00K USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | Inventory, Net |
| Payables | 387.00K USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $17.99M | $4.19M | $742.00K | (m) | (m) | (m) | $387.00K | (m) | 4.29× |
| 2026-03-31 | $21.34M | $4.03M | $3.82M | (m) | (m) | (m) | $927.00K | (m) | 5.30× |
| 2025-12-31 | $20.90M | $3.81M | $5.89M | (m) | (m) | (m) | $544.00K | (m) | 5.49× |
| 2025-09-30 | $21.92M | $3.21M | $3.46M | (m) | (m) | (m) | $526.00K | (m) | 6.83× |
| 2025-06-30 | $7.70M | $2.63M | $6.79M | (m) | (m) | (m) | $835.00K | (m) | 2.93× |
| 2025-03-31 | $6.18M | $1.99M | $5.39M | (m) | (m) | (m) | $326.00K | (m) | 3.11× |
| 2024-12-31 | $9.42M | $2.65M | $8.86M | (m) | (m) | (m) | $670.00K | (m) | 3.56× |
| 2024-09-30 | $12.20M | $2.76M | $11.12M | (m) | (m) | (m) | $396.00K | (m) | 4.42× |
| 2024-06-30 | $16.04M | $3.27M | $13.42M | (m) | (m) | (m) | $808.00K | (m) | 4.90× |
| 2024-03-31 | $19.95M | $3.34M | $12.12M | (m) | (m) | (m) | $1.27M | (m) | 5.97× |
| 2023-12-31 | $11.58M | $4.51M | $5.72M | (m) | (m) | (m) | $1.34M | (m) | 2.57× |
| 2023-09-30 | $14.42M | $3.57M | $13.39M | (m) | (m) | (m) | $1.03M | $0.00 | 4.04× |
| 2023-06-30 | $8.84M | $4.22M | $7.41M | (m) | (m) | (m) | $1.21M | $0.00 | 2.09× |
| 2023-03-31 | $17.35M | $9.46M | $13.35M | (m) | (m) | (m) | $1.40M | $3.32M | 1.83× |
| 2022-12-31 | $24.57M | $13.77M | $15.28M | (m) | (m) | (m) | $1.26M | $5.36M | 1.78× |
| 2022-09-30 | $24.54M | $15.65M | $12.73M | (m) | $512.00K | $874.00K | $2.00M | $7.89M | 1.57× |
| 2022-06-30 | $32.00M | $17.69M | $15.16M | (m) | $364.00K | $901.00K | $2.40M | $9.89M | 1.81× |
| 2022-03-31 | $42.81M | $17.03M | $21.82M | (m) | $184.00K | $1.04M | $2.71M | $8.81M | 2.51× |
| 2021-12-31 | $50.49M | $18.51M | $7.66M | (m) | (m) | (m) | $917.00K | $8.33M | 2.73× |
| 2021-09-30 | $51.75M | $17.07M | $13.27M | (m) | $153.00K | $1.56M | $2.23M | $8.78M | 3.03× |
| 2021-06-30 | $58.97M | $15.19M | $26.33M | (m) | $104.00K | $1.36M | $1.94M | $8.76M | 3.88× |
| 2021-03-31 | $71.31M | $15.54M | $34.36M | (m) | $658.00K | $1.42M | $3.23M | $8.75M | 4.59× |
| 2020-12-31 | $46.83M | $17.64M | $27.27M | (m) | $635.00K | $1.63M | $2.74M | $8.73M | 2.66× |
| 2020-09-30 | $47.80M | $16.56M | $19.97M | (m) | $1.13M | $1.98M | $2.00M | $8.72M | 2.89× |
| 2020-06-30 | $48.62M | $16.43M | $21.79M | (m) | $195.00K | $2.64M | $2.40M | $8.71M | 2.96× |
| 2020-03-31 | $58.05M | $15.72M | $23.89M | (m) | $567.00K | $3.10M | $3.25M | $6.61M | 3.69× |
| 2019-12-31 | $71.69M | $13.61M | $14.68M | (m) | $432.00K | $3.29M | $1.72M | $4.63M | 5.27× |
| 2019-09-30 | $85.67M | $11.43M | $21.95M | (m) | $244.00K | $2.98M | $2.65M | $2.08M | 7.49× |
| 2019-06-30 | $96.82M | $8.29M | $65.07M | (m) | $221.00K | $2.84M | $2.33M | (m) | 11.69× |
| 2019-03-31 | $95.34M | $18.95M | $73.31M | (m) | $221.00K | $2.40M | $3.70M | $10.03M | 5.03× |
| 2018-12-31 | $107.99M | $15.93M | $87.97M | (m) | $49.00K | $854.00K | $2.07M | $8.61M | 6.78× |
| 2018-09-30 | $66.00M | $14.47M | $57.57M | (m) | $187.00K | $856.00K | $1.77M | $8.37M | 4.56× |
| 2018-06-30 | $52.96M | $13.21M | $33.27M | (m) | $773.00K | $663.00K | $1.80M | $8.14M | 4.01× |
| 2018-03-31 | $53.66M | $13.25M | $43.60M | (m) | $772.00K | $666.00K | $2.30M | $7.92M | 4.05× |
| 2017-12-31 | $63.41M | $13.66M | $52.90M | (m) | $1.53M | $956.00K | $1.42M | $7.73M | 4.64× |
| 2017-09-30 | $71.07M | $14.87M | $67.94M | (m) | $1.34M | $969.00K | $1.25M | $9.25M | 4.78× |
| 2017-06-30 | $66.77M | $13.56M | $62.15M | (m) | $2.07M | $1.58M | $1.03M | $7.13M | 4.92× |
| 2017-03-31 | $77.97M | $12.75M | $72.33M | (m) | $2.71M | $1.85M | $1.69M | $5.06M | 6.11× |
| 2016-12-31 | $89.05M | $10.19M | $80.31M | (m) | $5.83M | $2.15M | $1.56M | $2.91M | 8.74× |
| 2016-09-30 | $96.92M | $15.53M | $92.46M | (m) | $2.01M | $1.38M | $1.35M | $9.18M | 6.24× |
| 2016-06-30 | $105.55M | $21.03M | $97.80M | (m) | $4.18M | $1.33M | $2.86M | $13.94M | 5.02× |
| 2016-03-31 | $112.79M | $16.80M | $105.43M | (m) | $3.21M | $910.00K | $3.60M | $9.19M | 6.71× |
| 2015-12-31 | $118.95M | $12.78M | $107.92M | (m) | $3.29M | $466.00K | $1.56M | $4.54M | 9.31× |
| 2015-09-30 | $122.59M | $7.88M | $95.04M | (m) | $17.38M | (m) | $1.70M | (m) | 15.55× |
| 2015-06-30 | $53.52M | $13.31M | $35.84M | (m) | (m) | (m) | $1.60M | $9.51M | 4.02× |
| 2015-03-31 | $65.42M | $15.36M | $49.14M | (m) | (m) | (m) | $2.69M | $9.29M | 4.26× |
| 2014-12-31 | $76.30M | $13.73M | $60.04M | (m) | $0.00 | (m) | $2.43M | $6.86M | 5.56× |
| 2014-09-30 | $86.64M | $10.37M | $70.24M | (m) | (m) | (m) | $2.87M | $4.51M | 8.36× |
| 2014-06-30 | $93.22M | $8.74M | $77.73M | (m) | (m) | (m) | $2.80M | $2.21M | 10.67× |
| 2014-03-31 | $93.97M | $4.61M | $77.59M | (m) | (m) | (m) | $2.19M | (m) | 20.39× |
| 2013-12-31 | $104.56M | $6.87M | $88.40M | (m) | (m) | (m) | $2.34M | (m) | 15.22× |
| 2013-09-30 | $77.00M | $12.43M | $60.80M | (m) | (m) | (m) | $1.25M | $8.13M | 6.20× |
| 2013-06-30 | $35.23M | $12.12M | $21.92M | (m) | (m) | (m) | $1.30M | $7.89M | 2.91× |
| 2013-03-31 | $50.33M | $14.98M | $37.08M | (m) | (m) | (m) | $3.94M | $7.66M | 3.36× |
| 2012-12-31 | $61.77M | $14.33M | $47.93M | (m) | (m) | (m) | $2.23M | $7.44M | 4.31× |
| 2012-09-30 | $25.30M | $12.23M | $3.72M | (m) | (m) | (m) | $2.86M | $7.23M | 2.07× |
| 2012-06-30 | $33.69M | $10.69M | $7.54M | (m) | (m) | (m) | $1.20M | $7.01M | 3.15× |
| 2012-03-31 | $31.07M | $8.95M | $4.47M | (m) | (m) | (m) | $1.14M | $5.68M | 3.47× |
| 2011-12-31 | $38.15M | $7.84M | $7.79M | (m) | (m) | (m) | $1.53M | $3.80M | 4.86× |
| 2011-09-30 | $34.08M | $5.09M | $1.82M | (m) | (m) | (m) | $2.63M | $681.00K | 6.69× |
| 2011-06-30 | $39.01M | $3.78M | $18.76M | (m) | (m) | (m) | $1.85M | (m) | 10.33× |
| 2010-12-31 | $5.78M | $13.41M | $3.06M | (m) | (m) | (m) | $543.00K | $5.20M | 0.43× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |